​

Quest Diagnostics (DGX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

DGX Stock Forecast

Quest Diagnostics (DGX) stock forecast, based on 34 Wall Street analysts, predicts a 12-month average price target of $246.67, with a high of $260.00 and a low of $225.00. This represents a 4.76% increase from the last price of $235.46.

$100 $140 $180 $220 $260 $300 High: $260 Avg: $246.67 Low: $225 Last Closed Price: $235.46

DGX Stock Rating

Quest Diagnostics stock's rating consensus is Hold, based on 34 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 13 Buy (38.24%), 18 Hold (52.94%), 3 Sell (8.82%), and 0 Strong Sell (0.00%).

Hold
Total 34 0 3 18 13 Strong Sell Sell Hold Buy Strong Buy

DGX Price Target Upside V Benchmarks

TypeNameUpside
StockQuest Diagnostics4.76%
SectorHealthcare Stocks 15.45%
IndustryDiagnostics & Research Stocks7.61%

Price Target Trends

1M3M12M
# Anlaysts1728
Avg Price Target$245.00$246.14$218.71
Last Closing Price$235.46$235.46$235.46
Upside/Downside4.05%4.54%-7.11%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 26277-117
Aug, 26277-117
Jul, 26278-118
Jun, 26279--18
May, 26279--18
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 08, 2026UBS$245.00$235.584.00%4.05%
Jul 29, 2026Argus Research$260.00$235.3510.47%10.42%
Jul 24, 2026Kevin CaliendoUBS$232.00$231.300.30%-1.47%
Jul 24, 2026Robert W. Baird$255.00$227.9011.89%8.30%
Jul 23, 2026Barclays$250.00$227.909.70%6.18%
Jul 23, 2026Jefferies$245.00$227.907.50%4.05%
Jul 13, 2026Robert W. Baird$236.00$207.4413.77%0.23%
Apr 21, 2026Evercore ISI$225.00$205.189.66%-4.44%
Apr 21, 2026Jefferies$225.00$205.189.66%-4.44%
Apr 08, 2026Evercore ISI$210.00$198.815.63%-10.81%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 08, 2026UBSNeutralNeutralhold
Jul 24, 2026UBSNeutralNeutralhold
Jul 23, 2026BarclaysOverweightOverweighthold
Jul 23, 2026JefferiesBuyBuyhold
Apr 21, 2026JefferiesBuyBuyhold
Feb 11, 2026UBSNeutralNeutralhold
Feb 11, 2026CitigroupNeutralNeutralhold
Feb 10, 2026JefferiesBuyBuyhold
Jan 30, 2026BarclaysEqual-WeightOverweightupgrade
Oct 27, 2025Piper SandlerNeutralNeutralhold

Financial Forecast

EPS Forecast

$7 $8 $9 $10 $11 $12 $13 $14 $15 $16 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$15.90$8.12$7.59$7.80$8.87---
Avg Forecast$14.12$9.85$8.71$8.90$9.73$10.51$11.56$12.71
High Forecast$14.81$10.03$8.75$8.93$9.77$12.37$12.45$13.00
Low Forecast$13.49$9.53$8.68$8.87$9.70$9.86$10.67$12.13
Surprise %12.61%-17.56%-12.86%-12.36%-8.84%---

Revenue Forecast

$9B $10B $10B $11B $12B $13B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$10.79B$9.88B$9.25B$9.87B$11.04B---
Avg Forecast$10.74B$9.83B$9.22B$9.83B$10.71B$11.13B$11.68B$12.06B
High Forecast$11.15B$9.97B$9.24B$9.84B$10.84B$11.17B$11.88B$12.27B
Low Forecast$10.37B$9.58B$9.20B$9.81B$10.50B$11.10B$11.49B$11.63B
Surprise %0.44%0.54%0.39%0.43%3.06%---

Net Income Forecast

$500M $900M $1B $2B $2B $3B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.00B$946.00M$854.00M$871.00M$992.00M---
Avg Forecast$1.71B$1.31B$850.00M$1.01B$1.10B$1.26B$1.38B$1.44B
High Forecast$2.06B$1.57B$1.02B$1.01B$1.10B$1.40B$1.41B$1.47B
Low Forecast$1.37B$1.04B$680.00M$1.00B$1.10B$1.11B$1.21B$1.37B
Surprise %16.48%-27.57%0.47%-13.39%-9.80%---

DGX Forecast FAQ

Is Quest Diagnostics stock a buy?

Quest Diagnostics stock has a consensus rating of Hold, based on 34 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 13 Buy, 18 Hold, 3 Sell, and 0 Strong Sell, reflecting a consensus that Quest Diagnostics is a neutral investment for most analysts.

What is Quest Diagnostics's price target?

Quest Diagnostics's price target, set by 34 Wall Street analysts, averages $246.67 over the next 12 months. The price target range spans from $225 at the low end to $260 at the high end, suggesting a potential 4.76% change from the previous closing price of $235.46.

How does Quest Diagnostics stock forecast compare to its benchmarks?

Quest Diagnostics's stock forecast shows a 4.76% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the diagnostics & research stocks industry (7.61%).

What is the breakdown of analyst ratings for Quest Diagnostics over the past three months?

  • September 2026: 11.76% Strong Buy, 41.18% Buy, 41.18% Hold, 0% Sell, 5.88% Strong Sell.
  • August 2026: 11.76% Strong Buy, 41.18% Buy, 41.18% Hold, 0% Sell, 5.88% Strong Sell.
  • July 2026: 11.11% Strong Buy, 38.89% Buy, 44.44% Hold, 0% Sell, 5.56% Strong Sell.

What is Quest Diagnostics’s EPS forecast?

Quest Diagnostics's average annual EPS forecast for its fiscal year ending in December 2026 is $10.51, marking a 18.49% increase from the reported $8.87 in 2025. Estimates for the following years are $11.56 in 2027, and $12.71 in 2028.

What is Quest Diagnostics’s revenue forecast?

Quest Diagnostics's average annual revenue forecast for its fiscal year ending in December 2026 is $11.13B, reflecting a 0.87% increase from the reported $11.04B in 2025. The forecast for 2027 is $11.68B, and $12.06B for 2028.

What is Quest Diagnostics’s net income forecast?

Quest Diagnostics's net income forecast for the fiscal year ending in December 2026 stands at $1.26B, representing an 26.63% increase from the reported $992M in 2025. Projections indicate $1.38B in 2027, and $1.44B in 2028.